|
⚲
|
| Keyboard |
| Paul Goldenheim | |
|---|---|
| Firm | |
| Address | 127 Western Avenue Allston, MA 02134 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Octagon Therapeutics Inc | 021-354262 | Director | 0.5 M of 0.5 M |
||
| Hydra Biosciences LLC | 021-341590 | Director | 0.0 M of 0.0 M |
||
| Octagon Therapeutics Inc | 021-324292 | Director | 0.5 M of 1.0 M |
||
| Hydra Biosciences Inc | 021-237027 | Director | 10.5 M of 17.7 M |
||
| Neurophage Pharmaceuticals Inc | 021-214921 | Director | 5.7 M of 17.1 M |
||
| Neurophage Pharmaceuticals Inc | 021-194074 | Director | 3.7 M of 8.3 M |
||
| Neurophage Pharmaceuticals Inc | 021-175217 | Director | 9.0 M of 9.0 M |
||
| Promedior Inc | 021-167385 | Director | 6.5 M of 6.5 M |
||
| Neurophage Pharmaceuticals Inc | 021-156414 | Director | 8.4 M of 12.4 M |
||
| Promedior Inc | 021-114118 | Director | 12.0 M of 12.0 M |
||